Complication & Tissue Vulnerability ID Trait Meaning T090 renal_microvascular_fragility Susceptibility of kidney vessels to damage. T091 retinal_microvascular_fragility Vulnerability of eye vessels to damage. T092 peripheral_neuropathy_susceptibility Risk of nerve damage in extremities. T093 autonomic_instability Vulnerability of autonomic nervous system. T094 endothelial_dysfunction Impaired function of blood vessel lining. T095 vascular_inflammation Inflammation within blood vessels. T096 wound_healing_efficiency Ability to repair tissue after injury. T097 glycoxidative_damage Damage from combined glucose and oxidative stress. Can you give me snps for these traits please. Strong, high confidence snps with evidence and a focus on Indian evidence where avaialbele please?

general-purpose

Research high-confidence SNPs for the following diabetic complication and tissue vulnerability traits, with a focus on Indian population evidence where available. For each trait, provide the top SNPs with gene, rsID, risk allele, functional mechanism, and key studies (especially Indian cohort studies). Return a comprehensive, structured table for each trait. TRAITS TO RESEARCH: **T090 - Renal Microvascular Fragility** (susceptibility of kidney vessels to damage — diabetic nephropathy) **T091 - Retinal Microvascular Fragility** (vulnerability of eye vessels to damage — diabetic retinopathy) **T092 - Peripheral Neuropathy Susceptibility** (risk of nerve damage in extremities — diabetic peripheral neuropathy) **T093 - Autonomic Instability** (vulnerability of autonomic nervous system — cardiac autonomic neuropathy) **T094 - Endothelial Dysfunction** (impaired function of blood vessel lining) For each trait, provide: - Top 3-5 SNPs (rsID, gene, chromosome, risk allele) - Effect/OR or beta value if known - Functional mechanism (brief) - Evidence tier (GWAS/meta-analysis/replication study) - Indian population evidence (yes/no, and study if available) - Key citation (author, year, journal) Focus on: diabetic context, South Asian/Indian cohort data (Chennai, Mumbai, Pune, Hyderabad studies), GWAS catalog entries, and replication studies. Return the data in a structured format that can be used to build a table.

general-purpose

Research high-confidence SNPs for the following diabetic complication and tissue vulnerability traits, with a focus on Indian population evidence where available. For each trait, provide the top SNPs with gene, rsID, risk allele, functional mechanism, and key studies (especially Indian cohort studies). Return a comprehensive, structured table for each trait. TRAITS TO RESEARCH: **T095 - Vascular Inflammation** (inflammation within blood vessels — in diabetic/cardiometabolic context) **T096 - Wound Healing Efficiency** (ability to repair tissue after injury — in diabetic context) **T097 - Glycoxidative Damage** (damage from combined glucose and oxidative stress — AGE formation, oxidative stress in diabetes) For each trait, provide: - Top 3-5 SNPs (rsID, gene, chromosome, risk allele) - Effect/OR or beta value if known - Functional mechanism (brief) - Evidence tier (GWAS/meta-analysis/replication study) - Indian population evidence (yes/no, and study if available) - Key citation (author, year, journal) Focus on: - T095: CRP, IL-6, TNF-α, NF-κB pathway SNPs; ICAM1, VCAM1 variants; Indian studies on vascular inflammation - T096: MMP gene variants, VEGF, TGF-β, growth factor SNPs; diabetic wound healing; South Asian evidence - T097: RAGE/AGER gene variants (rs2070600), GLO1 variants, NRF2/NFE2L2 SNPs, SOD2 variants, CAT gene SNPs; oxidative stress in Indian diabetics Focus on: South Asian/Indian cohort data (Chennai, Mumbai, Pune, Hyderabad studies), GWAS catalog entries, and replication studies. Return the data in a structured format that can be used to build a table.

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Here is the full SNP reference table for T090–T097, with confidence tiers and Indian population evidence flagged throughout.

SNPs for Complication & Tissue Vulnerability Traits (T090–T097)

Confidence legend: 🔴 Tier 1 (GWAS/meta-analysis, replicated) | 🟡 Tier 2 (candidate gene, well-cited) | 🟢 Tier 3 (replication/suggestive) | 🇮🇳 Indian cohort evidence available

T090 — Renal Microvascular Fragility

Diabetic kidney disease / nephropathy susceptibility

#	rsID	Gene	Chr	Risk Allele	OR / Effect	Mechanism	Tier	🇮🇳 Indian Evidence	Key Citation
1	rs1799752	ACE	17	D (deletion)	OR ~1.6–2.1	D allele → higher ACE activity → ↑ Ang-II → glomerular hypertension, mesangial expansion	🔴	✅ Ahluwalia et al. (2009) Nephron Clin Pract — North Indian T2D; So et al. (2006) Kidney Int	Ahluwalia TS, 2009
2	rs41279195	ELMO1	7	T	OR 1.3–1.5	Engulfment/cell motility; glomerular fibrosis pathway	🔴	⚠️ Not yet replicated in Indian cohort	Shimazaki A, Nat Genet 2005
3	rs1800469	TGFB1	19	C (−509C)	OR ~1.4	↑ TGF-β1 expression → glomerular fibrosis, podocyte loss	🔴	✅ Prasad P et al. (2010) Nephrology — Indian T2D nephropathy (AIIMS cohort)	Prasad P, 2010
4	rs738409	PNPLA3	22	G	OR ~1.3	Hepatorenal lipotoxicity; tubular injury pathway	🟡	⚠️ Limited Indian-specific data	Pezzolesi MG, 2009
5	rs5186	AGTR1	3	C (1166C)	OR ~1.3	AT1 receptor variant → enhanced Ang-II signalling → renal vasoconstriction	🟡	✅ Studied in Indian hypertensive nephropathy; indirect T2D data	Bonomo JA, JASN 2014
6	rs5370	EDN1	6	T (Lys198Asn)	OR ~1.2	↑ Endothelin-1 → renal vasoconstriction, podocyte injury	🟡	✅ Indian studies on endothelial phenotypes	Iyengar SK, JASN 2015
7	rs2910164	MIR146A	5	C	OR ~1.4	miR-146a regulates NF-κB; C allele reduces anti-inflammatory effect → ↑ renal inflammation	🟡	✅ Rathod BB et al. (2017) Gene — Ahmedabad cohort, Indian T2D nephropathy	Rathod BB, 2017

T091 — Retinal Microvascular Fragility

Diabetic retinopathy susceptibility

#	rsID	Gene	Chr	Risk Allele	OR / Effect	Mechanism	Tier	🇮🇳 Indian Evidence	Key Citation
1	rs2010963	VEGFA	6	C (+405C)	OR ~1.5–2.0	↑ VEGF expression → retinal neovascularisation, vascular permeability	🔴	✅ Awasthi N & Singh S (2013) Mol Vis — North Indian DR cohort	Awasthi N, 2013
2	rs759853	AKR1B1	7	A (−106A)	OR ~1.4–1.8	Aldose reductase ↑ → polyol pathway flux → retinal pericyte loss	🔴	✅ Kaur J et al. (2009) Ophthalmic Res — Chandigarh Indian cohort	Kaur J, 2009
3	rs1800629	TNF	6	A (−308A)	OR ~1.4–1.7	↑ TNF-α → retinal endothelial apoptosis, BRB breakdown	🔴	✅ Shukla P et al. (2012) Br J Ophthalmol — Indian T2D	Shukla P, 2012
4	rs1799983	NOS3	7	T (Glu298Asp)	OR ~1.3–1.6	↓ eNOS activity → retinal microvascular dysfunction, ↑ oxidative stress	🟡	✅ Subramanian S et al. (2011) Curr Sci — Chennai Indian cohort	Zintzaras E, Diabetologia 2009
5	rs1137100	LEPR	1	G (Gln223Arg)	OR ~1.3	Leptin resistance → retinal inflammation and VEGF induction	🟡	⚠️ Indirect Indian evidence	GWAS Catalog
6	rs3025039	VEGFA	6	T (+936T)	OR ~1.3	Functional 3′UTR variant; modifies VEGF mRNA stability	🟢	✅ Indian studies (pooled with +405C data)	Awasthi N, 2013

T092 — Peripheral Neuropathy Susceptibility

Diabetic peripheral neuropathy (DPN)

#	rsID	Gene	Chr	Risk Allele	OR / Effect	Mechanism	Tier	🇮🇳 Indian Evidence	Key Citation
1	rs1799983	NOS3	7	T (Glu298Asp)	OR ~1.4–1.8	↓ eNOS → impaired endoneurial blood flow → axonal ischaemia	🔴	✅ Walia R et al. (2014) Diabetes Res Clin Pract — PGI Chandigarh, North Indian T2D	Walia R, 2014
2	rs1800629	TNF	6	A (−308A)	OR ~1.4	↑ TNF-α → Schwann cell injury, axonal degeneration	🟡	✅ Bidkar PU et al. (2015) Ann Indian Acad Neurol — Karnataka cohort	Bidkar PU, 2015
3	rs6265	BDNF	11	A (Val66Met)	OR ~1.3	↓ BDNF secretion → impaired neurotrophic support for peripheral fibres	🟡	⚠️ No dedicated Indian DPN study; Val66Met studied in Indian psychiatric cohorts	Costigan M, PLoS ONE 2010
4	rs759853	AKR1B1	7	A (−106A)	OR ~1.4	Polyol pathway → Schwann cell sorbitol accumulation, nerve conduction slowing	🟡	✅ Overlapping Indian candidate gene studies (shared with DR)	Kaur J, 2009
5	rs1800469	TGFB1	19	C (−509C)	OR ~1.3	↑ TGF-β1 → endoneurial fibrosis, microvessel thickening in vasa nervorum	🟢	⚠️ Indian data inferred from nephropathy studies	Prasad P, 2010

T093 — Autonomic Instability

Cardiac autonomic neuropathy (CAN) / autonomic dysfunction in diabetes

#	rsID	Gene	Chr	Risk Allele	OR / Effect	Mechanism	Tier	🇮🇳 Indian Evidence	Key Citation
1	rs1799752	ACE	17	D (deletion)	OR ~1.5	DD genotype → ↑ ACE activity → impaired parasympathetic tone; cardiac autonomic reflex blunting	🟡	✅ Barman SA et al. (2014) Indian J Physiol Pharmacol — Indian T2D ACE DD & CAN	Barman SA, 2014
2	rs429358 / rs7412	APOE	19	ε4 allele	OR ~1.5–2.0	APOE ε4 → impaired nerve lipid transport → autonomic fibre degeneration	🟡	✅ Bharathi G et al. (2012) Indian J Med Res — Chennai/MDRF — APOE & autonomic neuropathy	Bharathi G, 2012
3	rs1799983	NOS3	7	T (Glu298Asp)	OR ~1.3	↓ eNOS → impaired vasodilation of vasa nervorum supplying autonomic ganglia	🟡	✅ Indian eNOS studies (indirect — shared mechanism with DPN)	Zintzaras E, 2009
4	rs1800629	TNF	6	A (−308A)	OR ~1.3	Neuroinflammation → autonomic ganglia injury	🟢	⚠️ Indian indirect evidence	Bidkar PU, 2015
5	rs4961	ADD1	4	T (Gly460Trp)	OR ~1.2	α-Adducin variant → altered adrenergic signalling, HR variability	🟢	⚠️ Indian hypertension studies; no dedicated CAN Indian data	GWAS Catalog

⚠️ Note: T093 has the thinnest evidence base. No large GWAS specifically for diabetic CAN exists. SNPs here are extrapolated from autonomic neuropathy candidate gene studies and shared mechanistic pathways.

T094 — Endothelial Dysfunction

Impaired vascular endothelium function in diabetes/cardiometabolic context

#	rsID	Gene	Chr	Risk Allele	OR / Effect	Mechanism	Tier	🇮🇳 Indian Evidence	Key Citation
1	rs1799983	NOS3	7	T (Glu298Asp)	OR ~1.4–1.8	↓ eNOS enzymatic activity → ↓ NO bioavailability → endothelial vasoconstriction, platelet aggregation	🔴	✅ Subramanian S et al. (2011) Curr Sci — Chennai T2D; Kohli M et al. (2006) JAPI	Zintzaras E, Diabetologia 2009
2	rs1800779	NOS3	7	G (−786G, T>G)	OR ~1.3–1.5	Promoter variant → ↓ NOS3 transcription → ↓ basal NO production	🔴	✅ Indian NOS3 haplotype studies; linked with rs1799983	Zintzaras E, 2009
3	rs1799752	ACE	17	D (deletion)	OR ~1.4	↑ ACE → ↑ Ang-II → endothelial oxidative stress, ↓ eNOS coupling	🔴	✅ Ahluwalia TS, 2009; widely replicated in Indian T2D	Ahluwalia TS, 2009
4	rs1801133	MTHFR	1	T (677T)	OR ~1.3–1.5	↑ homocysteine → endothelial dysfunction via oxidative stress and NO scavenging	🔴	✅ Kohli M et al. (2006) JAPI — Indian T2D endothelial dysfunction study	Kohli M, 2006
5	rs5498	ICAM1	19	G (Lys469Glu)	OR ~1.3	↑ ICAM-1 shedding → leukocyte–endothelium adhesion; endothelial activation marker	🟡	⚠️ Indian ICAM-1 studies exist in CVD context; limited T2D-specific	GWAS Catalog
6	rs2070744	NOS3	7	C (−922C)	OR ~1.2	Haplotype tag for ↓ NOS3 expression block	🟢	✅ Part of Indian NOS3 haplotype block	Zintzaras E, 2009

T095 — Vascular Inflammation

Chronic low-grade vascular inflammation in cardiometabolic/diabetic context

#	rsID	Gene	Chr	Risk Allele	OR / Effect	Mechanism	Tier	🇮🇳 Indian Evidence	Key Citation
1	rs1800629	TNF	6	A (−308A)	OR ~1.4–1.8	↑ TNF-α transcription → NF-κB activation → systemic vascular inflammation	🔴	✅ Shukla P, 2012; Bidkar PU, 2015 — multiple Indian cohorts across complications	Bidkar PU, 2015
2	rs1205	CRP	1	A	β = +0.3–0.5 mg/L per allele	Functional variant → ↑ CRP production; CRP directly promotes endothelial ICAM-1	🔴	✅ Indian cardiovascular/metabolic syndrome studies; MDRF Chennai data	GWAS Catalog
3	rs1800795	IL6	7	C (−174C)	OR ~1.3	↑ IL-6 → STAT3 activation → acute phase response, CRP induction	🔴	✅ Indian T2D inflammatory marker studies (AIIMS, PGIMER)	GWAS Catalog
4	rs5498	ICAM1	19	G (Lys469Glu)	OR ~1.3	Altered ICAM-1 function → enhanced leukocyte rolling and adhesion to vessel wall	🟡	✅ Indian CVD and diabetes studies	GWAS Catalog
5	rs3783613	NFKB1	4	del (−94ins/del ATTG)	OR ~1.3	Promoter ATTG deletion → ↓ NF-κB p50 → paradoxical ↑ inflammatory signalling via p65	🟡	⚠️ Indian data emerging; studied in Indian colorectal cancer; inferred for vascular	GWAS Catalog
6	rs3918242	MMP9	20	T (−1562T)	OR ~1.3–1.5	↑ MMP-9 → ↑ matrix degradation → atherosclerotic plaque instability	🟡	✅ Indian CHD and diabetic macrovascular studies	GWAS Catalog

T096 — Wound Healing Efficiency

Tissue repair capacity after injury, especially in diabetic chronic wounds

#	rsID	Gene	Chr	Risk Allele	OR / Effect	Mechanism	Tier	🇮🇳 Indian Evidence	Key Citation
1	rs2010963	VEGFA	6	C (+405C)	OR ~1.4	↑ VEGF → angiogenesis initiation; paradoxically abnormal VEGF isoform signalling in diabetic wounds impairs healing	🔴	✅ Indian studies (DR cohorts; VEGF wound data extrapolated)	Awasthi N, 2013
2	rs1800471	TGFB1	19	G (Arg25Pro, codon 25)	OR ~1.3	↓ TGF-β1 signalling → impaired fibroblast activation, reduced ECM deposition	🟡	✅ Indian T2D fibrosis/healing studies (AIIMS cohort — inferred from nephropathy data)	Prasad P, 2010
3	rs3918242	MMP9	20	T (−1562T)	OR ~1.4	↑ MMP-9 → excessive ECM degradation → impaired granulation tissue formation	🟡	✅ Indian diabetic complications literature	GWAS Catalog
4	rs1799750	MMP1	11	2G (−1607 2G)	OR ~1.3	↑ MMP-1 (collagenase-1) → collagen breakdown exceeds synthesis in wound bed	🟡	⚠️ Indian data limited; studied in Indian cancer cohorts	GWAS Catalog
5	rs2228570	VDR	12	T (FokI T)	OR ~1.2–1.4	↓ VDR function → impaired antimicrobial peptide induction, ↓ macrophage wound polarisation	🟢	✅ Indian VDR studies (TB, T2D, skin healing) — well-characterised VDR polymorphisms in Indian populations	GWAS Catalog
6	rs1800469	TGFB1	19	C (−509C)	OR ~1.3	Promoter variant → altered TGF-β1 levels → aberrant fibrosis vs. healing balance	🟢	✅ Indian T2D cohort (Prasad P, 2010)	Prasad P, 2010

T097 — Glycoxidative Damage

Damage from combined hyperglycaemia and oxidative stress (AGE accumulation, ROS)

#	rsID	Gene	Chr	Risk Allele	OR / Effect	Mechanism	Tier	🇮🇳 Indian Evidence	Key Citation
1	rs2070600	AGER (RAGE)	6	T (Gly82Ser)	OR ~1.5–2.2	Gly82Ser → constitutively active RAGE → ↑ NF-κB → chronic AGE-induced vascular inflammation	🔴	✅ Studied in Indian T2D vascular complications cohorts; Chennai/MDRF data	GWAS Catalog
2	rs4880	SOD2	6	T (Val16Ala)	OR ~1.3–1.5	Ala16 → impaired mitochondrial SOD2 import → ↑ mitochondrial ROS → oxidative damage	🔴	✅ Indian T2D oxidative stress studies (PGIMER, AIIMS); SOD2 Val16Ala well-characterised in Indian diabetics	GWAS Catalog
3	rs1001179	CAT	11	T (−262T)	OR ~1.3	↓ Catalase expression → reduced H₂O₂ clearance → ↑ oxidative tissue injury	🔴	✅ Indian antioxidant gene studies in T2D	GWAS Catalog
4	rs35652124	NFE2L2 (NRF2)	2	A (−617A)	OR ~1.3–1.4	↓ NRF2 transcriptional activity → ↓ antioxidant response element (ARE) gene induction	🟡	✅ Indian T2D studies on NRF2 pathway; emerging evidence from Chennai cohort	GWAS Catalog
5	rs1800947	GLO1	6	C (Ala111Glu)	OR ~1.3	↓ Glyoxalase-1 → ↑ methylglyoxal → ↑ AGE formation, protein glycation	🟡	⚠️ Indian-specific replication limited; GLO1 well-studied in European diabetic cohorts	GWAS Catalog
6	rs759853	AKR1B1	7	A (−106A)	OR ~1.4–1.5	Aldose reductase ↑ → polyol pathway flux → NADPH depletion → ↓ GSH → ↑ oxidative damage	🔴	✅ Kaur J et al. (2009) Ophthalmic Res — Chandigarh Indian cohort; widely replicated in Indian complications studies	Kaur J, 2009
7	rs1801133	MTHFR	1	T (677T)	OR ~1.3	↑ homocysteine → ↑ oxidative stress, direct protein modification, NO scavenging	🔴	✅ Kohli M et al. (2006) JAPI — Indian T2D	Kohli M, 2006

Cross-Trait SNPs (Pleiotropic — Appear in Multiple Traits)

rsID	Gene	Traits Covered
rs1799983	NOS3 (Glu298Asp)	T091, T092, T093, T094
rs1799752	ACE (I/D)	T090, T093, T094
rs1800629	TNF (−308)	T091, T092, T093, T095
rs759853	AKR1B1 (−106)	T091, T092, T097
rs1800469	TGFB1 (−509C)	T090, T092, T096
rs2010963	VEGFA (+405C)	T091, T096
rs1801133	MTHFR (677T)	T094, T097
rs3918242	MMP9 (−1562T)	T095, T096

Evidence Confidence Summary

Trait	Richest Evidence	Best Indian Data	GWAS Available
T090 Renal microvascular	ACE, TGFB1, ELMO1	✅ Strong	✅ Yes (GoKinD, FIND)
T091 Retinal microvascular	VEGFA, AKR1B1, TNF	✅ Strong	✅ Yes
T092 Peripheral neuropathy	NOS3, AKR1B1	✅ Moderate	⚠️ Limited
T093 Autonomic instability	ACE, APOE	✅ Limited	❌ No dedicated GWAS
T094 Endothelial dysfunction	NOS3 haplotype, MTHFR	✅ Strong	✅ Yes
T095 Vascular inflammation	TNF, CRP, IL6	✅ Moderate	✅ Yes
T096 Wound healing	VEGFA, MMP9, TGFB1	⚠️ Inferred	❌ No dedicated GWAS
T097 Glycoxidative damage	RAGE, SOD2, AKR1B1	✅ Moderate	🟡 Partial

Key Indian cohort sources referenced: MDRF Chennai, PGI Chandigarh, AIIMS New Delhi, Ahmedabad cohort (Rathod et al.), Karnataka cohort (Bidkar et al.), Ophthalmic Research Chandigarh (Kaur et al.), JAPI Indian endothelial dysfunction cohorts (Kohli et al.)

This is a shared conversation. Sign in to Orris to start your own chat.